Health ❯Healthcare

Medications

Drug Safety Health Conditions Neurodevelopmental Disorders Anxiety Appetite Regulation Drug Pricing Maternal Health Endocrinology Weight Loss Drugs Management Changes

Bariatric Surgery Surpasses GLP-1 Drugs in Real-World Weight Loss

New findings show surgery delivers more durable weight loss with lower psychiatric risks compared to weekly semaglutide or tirzepatide injections.

Tufts Chemists Unveil Four-Receptor Obesity Drug to Challenge Bariatric Surgery

GLP-1 Agonists Tied to Higher Risk of Macular Degeneration and Rare Optic Neuropathy

Mounjaro Delivers Rapid Weight Loss as UK Health Officials Warn of Serious Risks

Biannual Zilebesiran Injections Significantly Lower Blood Pressure in Resistant Hypertension

‘Ozempic Teeth’ Emerges as a Serious Dental Risk for Weight-Loss Drug Users

Study Confirms Triptan Use in Pregnancy Does Not Increase Neurodevelopmental Risks

Cardiologist Follow-Up Found to Halve Mortality Risk in Heart Failure Patients

Paramedic Pleads Guilty to Secretly Administering Abortion Drug to Pregnant Woman

Study Links Medicaid Disenrollment to Increased Mortality Among Low-Income Seniors

Tirzepatide Outperforms Semaglutide in Weight-Loss Trial

GLP-1 Drugs Found to Cut Alcohol Consumption and Improve Mental Health

Semaglutide Shows Potential to Transform Treatment of Advanced Fatty Liver Disease

Federal Judge Upholds FDA Ban on Compounded Ozempic and Wegovy Copies

Diabetes Drug Metformin Reduces Knee Pain in Osteoarthritis Patients, Study Finds

Novo Nordisk Seeks FDA Approval as Eli Lilly's Weight-Loss Pill Advances

Eli Lilly's Oral GLP-1 Pill Demonstrates Success in Phase 3 Trials

GLP-1 Drugs Like Ozempic Linked to Lower Dementia Risk in New Studies

Trump Administration Rejects Biden-Era Plan to Expand Medicare Coverage for Weight-Loss Drugs

Benadryl Liquid Elixir Recalled Over Child-Resistant Packaging Violation